DGRADX
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97312042
- Registration number
- 7656980
- Mark type
- Stylized text
- Filed
- 14 Mar 2022
- Published for opposition
- 03 Dec 2024
- Registered
- 21 Jan 2025
- Attorney of record
- Nicholas D. Wells
Goods and services
- Class 042 — Scientific and technological services: Application service provider, namely, hosting online non-downloadable computer software platforms for medical research in the field of drug discovery and drug development; Programming of a drug discovery and development computer software platform for others; Online electronic data storage; Consultancy and assistance services in the nature of website design consultancy and computer software consulting, via an online website and data network platform, in the field of medical sciences; Web site hosting services of an online platform for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research, namely in the medical field of cell metabolism, ageing and cell health
Owner
- Booster Therapeutics GmbH, Berlin, DE
- Booster Therapeutics GmbH, Berlin, DE
- Booster Therapeutics GmbH, Berlin, DE
Prosecution history
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 05 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 05 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN
- 24 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Oct 2024 — ASSIGNED TO LIE
- 24 Oct 2024 — ASSIGNED TO LIE
- 19 Jul 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED